KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Charles River Laboratories International (CRL) Consolidated Net Income: 2009-2025

Historic Consolidated Net Income for Charles River Laboratories International (CRL) over the last 17 years, with Sep 2025 value amounting to $55.6 million.

  • Charles River Laboratories International's Consolidated Net Income fell 20.97% to $55.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$79.6 million, marking a year-over-year decrease of 118.60%. This contributed to the annual value of $25.3 million for FY2024, which is 94.74% down from last year.
  • As of Q3 2025, Charles River Laboratories International's Consolidated Net Income stood at $55.6 million, which was up 5.43% from $52.7 million recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Consolidated Net Income registered a high of $189.1 million during Q4 2022, and its lowest value of -$213.7 million during Q4 2024.
  • Its 3-year average for Consolidated Net Income is $58.2 million, with a median of $74.5 million in 2024.
  • As far as peak fluctuations go, Charles River Laboratories International's Consolidated Net Income skyrocketed by 48.94% in 2022, and later slumped by 213.12% in 2024.
  • Quarterly analysis of 5 years shows Charles River Laboratories International's Consolidated Net Income stood at $139.8 million in 2021, then skyrocketed by 35.24% to $189.1 million in 2022, then decreased by 0.08% to $189.0 million in 2023, then plummeted by 213.12% to -$213.7 million in 2024, then dropped by 20.97% to $55.6 million in 2025.
  • Its Consolidated Net Income stands at $55.6 million for Q3 2025, versus $52.7 million for Q2 2025 and $25.9 million for Q1 2025.